Parkinson’s disease psychosis management: an evidence based, experience informed, pragmatic approach-Reference-Cited by-同舟云学术

Parkinson’s disease psychosis management: an evidence based, experience informed, pragmatic approach

Published:2024-01-22 Issue:2 Volume:25 Page:149-156
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Friedman Joseph H.¹^ORCID

Affiliation:

1. Butler Hospital, Movement Disorders Program, Warren Alpert Medical School of Brown University, Providence, RI, USA

Funder

No funding

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2316135

Reference71 articles.

1. Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson’s Disease Psychosis: Systematic Review and Network Meta-Analysis

2. Layton JB, McQuay L, Forns J, et al. Risk of mortality associated with pimavanserin compared with atypical antipsychotics in patients with Parkinson’s disease-related psychosis. Presented at the 2022 American Society of Clinical Psychopharmacology (ASCP); 2022 May 31; Scottsdale, AZ.

3. Mortality in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study

4. Falls and Fractures in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis;Schizophrenia Research;2024-06

2. Promoting safer and wider worldwide use of clozapine;Schizophrenia Research;2024-03